However, there are currently few studies on the difference in the role of CLDN10 in VHL-deficient and VHL wild-type ccRCC cells, and this will be one of the questions we will have to address in the near future. This evidence concerns the gene CLDN10 and nonpapillary renal cell carcinoma.